American Gene Technologies International americangene.com


Public lists: Pharma Startups (6570)

American Gene Technologies is developing and commercializing genetic medicines targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma (liver cancer, or HCC).

American Gene Technologies is developing and commercializing genetic medicines targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma (liver cancer, or HCC).

Company (Alive / Active)

Phone: 301-337-2100

Fax:

9640 Medical Center Drive

Rockville, 20850
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
American Gene Technologies International $3.5M Apr 13, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related American Gene Technologies International Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods and compositions for the activation of gamma-delta t-cells Aug 02, 2019 Sep 15, 2020 Patent
Combination vectors and methods for treating cancer Mar 09, 2017 Sep 08, 2020 Patent
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules Dec 21, 2011 Feb 04, 2020 Patent
Hiv pre-immunization and immunotherapy Dec 12, 2018 Dec 03, 2019 Patent
Methods and compositions for the activation of gamma-delta t-cells Jun 14, 2018 Nov 12, 2019 Patent
See all 26 patents